美国企业如何从印度的研发税收激励中获益

发布日期:
September 29, 2025

目录

联系我们
感谢您!我们已收到您的提交信息!
糟糕!提交表单时出错了。

立足本土,
服务全球

我们以专业和清晰的视角,为您提供跨境业务支持。
预约咨询

Considering expanding R&D operations to India? US companies can capitalize on a favorable tax environment that offers a 100% deduction on eligible research expenses, covering in-house and partnered innovations.

India’s flexible regulations, cost-effective talent, and reduced customs and GST rates speed product development while minimizing overhead. This environment helps American firms diversify global R&D investments, improving cash flow and technological growth. 

This guide explains how US companies can strategically benefit from tax incentives for R&D in India, going through the regulations to take full advantage.

Key Takeaway

  • Substantial Tax Benefits Under Section 35: US businesses in India can claim a 100% deduction on revenue and capital R&D expenditures, significantly lowering their taxable income and improving innovation cost-efficiency.
  • DSIR Recognition Opens Broad Incentives: Recognition by India’s DSIR allows zero customs duty on R&D imports, GST reductions, and access to government grants, accelerating cost savings and operational ease for US firms.
  • Extensive Deductible R&D Expenses: Eligible deductions cover operational costs like salaries, utilities, raw materials, and capital equipment, excluding land, allowing complete financial relief across diverse R&D activities.
  • Full Compliance and Documentation Requirements: Companies must maintain detailed financial, technical, and statutory records, including DSIR approval, and file annual returns like Form 3CL to sustain their eligibility for tax incentives.
  • Industry-Specific Incentives Improve Strategic R&D: Pharma, IT, electronics, aerospace, and renewable sectors benefit from customized incentives, such as weighted deductions, patent tax rates, and accelerated depreciation, driving more focused investment.

Understanding Tax Incentives for R&D in India

Tax incentives for R&D in India represent a comprehensive framework designed by the government to promote scientific research and development activities across industries. These tax incentives operate primarily through Section 35 of the Income Tax Act 1961, which provides substantial deductions for businesses and organizations investing in research activities.

The system aims to reduce the financial burden of R&D investments while encouraging companies to develop new technologies, products, and processes that can drive economic growth and technological advancement.

  • Tax incentives for R&D in India have gained significant momentum following the government's commitment to allocate ₹20,000 crore for private sector-driven research and development in Budget 2025-26, marking a substantial increase from previous allocations.
  • This framework contains various types of deductions, customs duty exemptions, and GST benefits that make India an attractive destination for both domestic and international companies seeking to establish research facilities.

What does Tax Incentive for R&D in India Mean for US Businesses?

Tax Incentive for R&D in India offers clear financial advantages to US companies investing in research activities within the country. Recognizing the specific provisions and benefits can help American firms effectively plan and allocate resources for their innovation efforts.

What does Tax Incentive for R&D in India Mean for US Businesses?

Below are key details tracing how these incentives apply to US businesses operating in India.

  • Section 35 Tax Deduction: US companies operating in India through subsidiaries or permanent establishments can claim a 100% deduction on both revenue and capital R&D expenditures under Section 35 of the Income Tax Act.
  • DSIR Recognition: Foreign firms registered in India, including US subsidiaries, qualify for Department of Scientific and Industrial Research recognition, showing benefits like tax deductions and customs duty exemptions on R&D imports.
  • Customs Duty and GST Benefits: DSIR-approved entities enjoy zero basic customs duty on equipment and inputs, plus reduced GST rates, 5% for interstate and 2.5% CGST plus 2.5% SGST on intrastate transactions.
  • Accelerated Depreciation: US companies can claim 100% depreciation on research assets in the first year, optimizing capital expense treatment.
  • Pre-Operational R&D Deductions: Research expenses incurred up to three years before starting business operations in India are deductible once operations commence.
  • Collaborative Research Contributions: Payments to approved Indian research bodies are deductible up to 100–150%, encouraging partnerships.
  • Expense Coverage: All operational expenses, including salaries, utilities, raw materials, and consumables, qualify for full deduction in the year incurred.
  • Exclusions and Documentation: Land costs are non-deductible, and detailed records and DSIR approvals are essential to claim benefits.
  • Access to Govt Support: DSIR-registered US subsidiaries may also access government grants, subsidized loans, and equity support for their R&D activities.

Plan ahead with expert insights that can help businesses go through global rules and minimise risks, and explore practical approaches in International Tax Planning Strategies for 2025.

Tax Incentives for R&D in India: Benefits Structure

Tax Incentives for R&D for US businesses in India come with a structured framework that defines how different research expenditures are recognized and deducted. Understanding the specific categories and their conditions can help set realistic expectations for tax planning and compliance.

Here’s a clear overview of the key benefits and requirements associated with these incentives.

Expenditure on Scientific Research Tax Deduction Rate Section Reference Key Requirements & Conditions Form Required
In-house revenue expenditure 100% of expenditure Section 35(1)(i) Must be related to business operations Not specified
In-house capital expenditure (excluding land & building) 100% of expenditure (land cost excluded) Section 35(1)(iv) Separate books required; excludes land & building costs Form 3CK for DSIR approval
Pre-commencement expenditure (within 3 years before business) 100% in the year the business commences Section 35(1)(i) Expenditure incurred within 3 years before business start Not specified
Payment to an approved scientific research company (Indian entity) 100% of payment Section 35(1)(iia) An Indian company with scientific research as its main objective Approval from the Income Tax Authority is required
Contribution to an approved research association/university 100% Section 35(1)(ii) The institution must be government-approved Not specified
Payment to national laboratory/IIT/university 100% Section 35(2AA) Recognized by the prescribed authority with an approved program Form 3CG for approval
Payment to specified person approved by prescribed authority 100% Section 35(2AA) Must be approved by the prescribed authority (DSIR) Form 3CG for approval
In-house R&D by biotechnology/manufacturing companies 100% Section 35(2AB) DSIR approval mandatory; biotech/manufacturing (excluding Eleventh Schedule) Form 3CK for DSIR approval, Form 3CL report
Capital expenditure on scientific research equipment 100% of capital expenditure Section 35(1)(iv) Equipment only; excludes land & building purchase Form 3CK for expenditure > INR 1 crore

Historical Context

The tax incentives for R&D in India have undergone substantial modifications:

  • Pre-2017: 200% weighted deduction under Section 35(2AB).
  • 2017-2021: Reduced to 150% weighted deduction.
  • 2021-Present: Further reduced to 100% standard deduction.

这代表了政策的转变,即从慷慨的加计扣除转向通过“专利盒”(Patent Box)制度专注于专利商业化的平衡方案。

保护品牌应从基础做起。您需要了解的一切尽在 如何在印度注册商标:分步指南。

分步指南:美国公司如何从印度的研发税收激励中获益

印度的研发税收激励为开展科学研究和开发活动的公司提供了显著的财务收益。这些扣除额主要受《所得税法》第35条管辖,允许企业对与经批准的研发活动相关的收入支出和资本支出申请100%的扣除。

在申请任何税收优惠之前,企业必须首先确认其是否符合核心资格要求。

资格要求

以下是这些企业必须满足的关键要求。

Aspect Details
Legal & Operational Status Must be registered in India under the Companies Act, 2013, including partnerships or LLPs.
Business History Three financial years must be completed since the start of operations.
R&D Infrastructure Must have identifiable facilities, qualified personnel, and defined R&D programs.
Facility Size & Location R&D activities must be carried out on the premises or in dedicated facilities of at least 1,000 sq. ft., in designated areas within India.
Technical Staff Must demonstrate the availability of sufficient skilled personnel for R&D operations.

仅满足资格条件是不够的;企业还需要获得科学与工业研究部(DSIR)的认可,以正式验证其内部研发部门的资质。

VJM Global的国际税务专家可协助企业处理复杂的跨境合规问题,同时提供符合印度及全球监管标准的资格认证、DSIR认可及结构化研发基础设施方案。 立即咨询我们的专家!

DSIR认可流程

DSIR Recognition Process

在印度获得DSIR认可需要遵循一套明确的流程,以验证内部研发部门的能力与合规性。以下是涉及的关键步骤概述。

  • 初始注册: 在DSIR网站在线注册,并通过专门门户网站提交内部研发部门的认可申请。
  • 提交申请: 通过特快专递将申请的电子版和纸质版连同证明文件提交至DSIR办公室。
  • DSIR会议: DSIR会通知申请人参加会议,进行现场视频演示,展示研发中心的能力。
  • 认可决定: DSIR将评估申请,并根据合规性指南和基础设施评估结果决定授予或拒绝认可。
  • 实地考察可能性: 根据申请要求和核实需要,DSIR团队可能会对研发中心进行实地考察。

在获得DSIR认可后,企业接下来的步骤是获得第35(2AB)条批准,以解锁扣除优惠。

Need an India subsidiary? We handle FDI approvals, taxation, and local compliance.

第35(2AB)条批准流程

根据第35(2AB)条申请税收优惠涉及正式的审批流程,该流程旨在确认合规性并允许对研发资本支出进行即时扣除。该流程的主要步骤如下。

Step Description
Form 3CK Application Submit Form 3CK to DSIR with detailed R&D information, audited financial statements, infrastructure details, and compliance certificates.
Agreement Execution Sign a formal agreement with the Secretary, DSIR, establishing cooperation in research and the audit of financial accounts.
Form 3CM Receipt The company receives an approval certificate in Form 3CM from DSIR for a specific period, as per DSIR guidelines.
Tax Benefit Eligible to claim a 100% deduction on approved capital R&D expenses in the first year without waiting for depreciation.

只有在正确文件的支持下,批准才有效,因此文档记录对企业而言至关重要。

文档要求

需要保存的关键文件包括以下内容。

  • 公司注册文件: 公司章程副本,证明其法律存在和公司结构。
  • 研发基础设施详情: 对研发部门活动、范围、目标、方法及研究项目成果的完整描述。
  • 财务记录: 近三年的年度报告、财务报表,以及研发费用的详细明细,包括材料、工资和设备成本。
  • 技术文档: 研发部门设计图,显示物理布局、基础设施详情、安装日期、设备价值及人员资质。
  • 法定合规性: 法定机构颁发的有效许可证和执照,用于证明在特定地点运营和建立研发中心的合法性。

初步批准仅仅是个开始;持续的合规性才能确保企业能够不间断地享受优惠。

Annual Compliance and Reporting

Here are the main requirements for annual compliance and documentation.

  • 3CL 表格提交:每年 10 月 31 日前提交 3CL 表格年度申报表,详细说明获批期间的研发支出及活动情况。
  • 独立账户维护:为每个研发中心维护独立账户,并由法定审计师进行年度审计,同时向科学与工业研究部(DSIR)提供副本。
  • 3CLA 表格认证:这 是一项新表格,要求会计师证明账户维护合规,且支出符合 DSIR 指南。
  • 内部审计要求:如有需要,对研发费用进行内部审计,确保支出符合获批的类别。

了解最新规则能在申报时产生显著影响。获取您所需的详细信息,请参阅《2025 年研发税收抵免:变更、申报与索赔》。

Tax incentives aren’t limited to income tax; GST and customs benefits can reduce upfront spending for R&D projects.

GST and Customs Benefits

The following benefits help lower the upfront costs related to R&D activities.

Benefit Description
Reduced GST Rate Maximum 5% IGST on eligible R&D purchases instead of the standard 18%, reducing R&D project costs.
Customs Duty Exemption Zero customs duty on imports of R&D equipment, spares, accessories, and consumables under specific notifications.
Import Procedures Apply to Customs with a DSIR certificate confirming exclusive R&D use, equipment details, and all supporting documents.
Pharmaceutical Benefits Duty-free import allowed for pharmaceutical reference standards and analytical equipment for biotechnology and pharma R&D.

Long-term benefits depend on strict record keeping and audits, as these form the backbone of compliance for businesses.

利用 VJM Global 在 GST 影响分析方面的深厚专业知识和定制化解决方案,获得降低的 GST 税率、关税豁免及合规的进口优惠,从而大幅降低研发项目的总成本。与我们联系!

Compliance and Record Keeping

The following facts cover essential compliance practices.

  • 审计要求:强制性审计与报告,以申请扣除额,并妥善维护研究成本记录,包括材料、工资和账单。
  • 文档标准:保存所有研发费用的详细记录,包括支持性发票、技术报告、项目信息及相关文件。
  • 评估时间表:所得税部门通常在申报两年后进行研发评估(即审查阶段),届时需提交 3CM 表格。
  • CBDT 争议解决:若与评估官员发生争议,事项将通过指定机构(DGIT 免税部门)并征得 DSIR 秘书同意后,提交至中央直接税委员会(CBDT)处理。

With VJM Global, entry to India is made simple; company registration, compliance, and ongoing support in one place.

Industry-Specific Opportunities for Tax Incentives for R&D in India

Tax Incentive for R&D in India varies notably across industries, reflecting the distinct demands and priorities of each sector. Recognizing how these incentives align with specific industry needs can clarify where the most relevant benefits lie.

The following breakdown highlights key opportunities available to different fields.

Industry Tax Incentive Summary
Pharmaceuticals 150% weighted deduction under Section 35(2AB); duty-free import for research equipment; 10% patent box tax rate.
IT & Software 150% deduction on in-house R&D; tax exemptions in Special Economic Zones (SEZs) for export profits; 10% concessional tax on patent income.
Electronics 150% weighted deduction; $3 billion government incentives for indigenous technology; duty exemptions for design and prototyping.
Automotive 150% R&D deduction; 40% accelerated depreciation on indigenous technology machinery; EV R&D incentives.
Aerospace & Defense Up to 45% capital subsidy; excise and utility duty exemptions; DRDO funding for MSMEs; patent-based benefits.
Renewable Energy 100% deduction on profits from solar/wind projects; accelerated depreciation on machinery; financial support programs.
Chemicals & Materials 150% deduction on R&D expenditure; import substitution incentives; tax benefits for environmental R&D compliance.
Agriculture & Food Weighted deductions on crop breeding and processing R&D; concessional tax on patent income; export promotion incentives.

How VJM Global Can Support US Businesses Claim Tax Incentives for R&D in India

VJM Global 通过印度的研发税收激励框架,为美国企业提供专业支持。我们的团队简化了复杂的监管与合规需求,使企业能够充分利用财政优势。

  • 深入的监管知识:全面了解印度的税法、关税豁免及 DSIR 认证程序,以优化研发索赔。
  • 端到端合规支持:处理文档、申报及报告要求,最大限度减少您团队的运营负担。
  • 专业的跨学科团队:德里 NCR 和孟买的资深专业人士提供及时、准确且以客户为中心的服务。
  • 技术驱动的流程:在整个合作过程中使用现代工具,确保高效与沟通透明。

借助 VJM Global 的专业知识,为您的研发运营奠定成功基础。立即联系我们,开始最大化您在印度的研发税收激励。

结语

The tax incentives for R&D in India framework offer US companies a strategic pathway to build innovation hubs in a cost-efficient setting. With 100% tax deductions, customs exemptions, and reduced corporate rates, the framework cultivates a fertile environment for research activities. Securing DSIR recognition for R&D operations opens further financial advantages while tapping into India’s skilled talent pool. 

VJM Global 专注于引导企业应对这些监管细微差别,助力企业实现税务优惠和运营效率的最大化。准备好利用印度的研发税收激励政策来实现您的创新目标了吗?

与我们联系,开启将您的研发投资转化为实质性增长的旅程。

常见问题

‍

1. 美国公司在未于印度设立常设机构的情况下,能否申请印度的研发税收激励?

不能。公司必须在印度设立常设机构或子公司,并为其内部研发部门获得 DSIR(科学与工业研究部)认证,方可根据第 35 条申请优惠。

2. 获得 DSIR 认证所需的最低投资额是多少?

没有具体的最低投资门槛,但公司必须证明其拥有专门的研发设施,并配备符合其研究目标的合格人员和设备。

3. 现行的 100% 扣除额与之前的超级扣除方案相比如何?

现行的 100% 扣除额取代了 2020 年逐步取消的早期 150%-200% 加计扣除方案。虽然优惠力度有所减弱,但对于研发投资者而言依然相当可观。

4. 软件开发活动是否符合研发税收优惠条件?

符合。如果软件开发活动涉及创建新算法、新技术或创新解决方案,并经 DSIR 认定为合法的研发活动,则可以享受优惠。

5. 如果研发支出超过当年的利润,可以结转吗?

可以。未抵扣的研发支出最多可结转八年,并用于抵扣未来利润,这为处于初期亏损阶段的企业提供了灵活性。

‍

VJM Global
探索 VJM Global 的专家见解、实用建议与最新动态
了解作者详情

最新博客